BEVERLY HILLS, Calif., July 19, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination and infection prevention company that specializes
in disinfection/decontamination sales and services, including the manufacturing, sale and licensing of its SteraMist™, a
hydrogen peroxide-based mist/fog that is registered with the U.S. Environmental Protection Agency (“EPA”) for use as a
Hospital-Healthcare Disinfectant Effective Broad-Spectrum Surface Disinfectant, today announced that shareholders voted in line
with the Board of Directors' recommendations on all proposals and elected all director nominees at the July 7, 2017 Annual Meeting
of Shareholders. Dr. Halden Shane, CEO and Chairman of the TOMI Board of Directors, stated, "On behalf of the entire TOMI
Board of Directors, we would like to thank the TOMI shareholders for the strong support of our directors, proposals and the
initiatives underway at the Company to improve results for all stakeholders." On July 12th the Company filed the
voting results with the U.S. Securities & Exchange Commission on a Form 8-K.
About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing environmental
solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier Binary Ionization Technology®
(BIT™) platform, which was invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA)
of the U.S. Department of Defense. BIT uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl
radical (OH ion), represented by the TOMI™ SteraMist™ brand of products, which produces a germ-killing aerosol that spreads like a
gas.
TOMI’s products are designed to service a broad spectrum of commercial structures including hospitals and
medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing
facilities, military barracks, police and fire departments, and athletic facilities. TOMI’s products and services have also been
used in single-family homes and multi-unit residences.
TOMI also develops training programs and application protocols for its clients and is a member in good standing
of The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection
Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association. For additional
information, visit www.tomimist.com or contact us at info@tomimist.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the
Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and
phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,”
“projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases.
All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future,
including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking
statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk
factors that could cause our actual results to differ materially from our anticipated results. The information provided in this
document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking
statements after the date of this release.
MEDIA RELATIONS CONTACTS Paul Varga Marketing and Communications (301) 628-2831 pvarga@tomimist.com